Macro Finance
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
CNBC Business·August 27, 2026·1 min read
The FDA approved a new daily HIV prevention pill from Gilead, designed to simplify treatment for patients already stable on a single-tablet regimen like Biktarvy. The approval expands options for those seeking to switch from existing daily oral pre-exposure prophylaxis, offering a more convenient alternative.
Read at CNBC BusinessDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.